SynthesisFrontiers in immunology2026

Clinical characteristics, management, and prognosis of pembrolizumab-induced immune-related oral mucositis.

Liuxian Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.